Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
- PMID: 22410637
- DOI: 10.1097/QAD.0b013e328350fb3c
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
Abstract
Objective: We investigated the dynamics of HIV RNA and HIV DNA levels after the commencement of raltegravir-based antiretroviral therapy (ART) in primary (PHI) and chronically HIV-infected (CHI) individuals (the PINT study).
Design: We recruited 8 PHI and 8 CHI ART-naive individuals who commenced a 1-year combination regimen of Truvada and the integrase inhibitor raltegravir.
Methods: Nonlinear mixed effects modelling was used to determine multiphasic decay of plasma HIV RNA levels (pVL), as well as dynamics of total, episomal [2-long terminal repeats (LTR)] and integrated HIV DNA in CD4 T cells from peripheral blood.
Results: Although pVL decreased faster through first and second phase for PHI individuals there was no difference in the final level reaching a mean of 9 copies/ml by week 16 that was maintained thereafter. Total HIV DNA and integrated HIV DNA levels from CHI patients were significantly higher than from PHI patients. However, at no time did 2-LTR levels differ between groups. Of note, 2-LTR circles exhibited an initial increase peaking at week 3 followed by biphasic decay with a half-life of 29 days. Second phase integrated HIV DNA levels were significantly correlated with duration of infection and consistent with this form of infection occurring at approximately 100 000 integration events per day in the absence of ART, achieving its 50% level 2 years after infection.
Conclusions: Integrated HIV DNA levels accumulate with duration of untreated HIV infection. The relatively short half-life and high levels of 2-LTR circles after 1 year support continued HIV transmission during ART.
Similar articles
-
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir.AIDS. 2011 Nov 13;25(17):2069-78. doi: 10.1097/QAD.0b013e32834b9658. AIDS. 2011. PMID: 21860347
-
Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients.J Antimicrob Chemother. 2014 Oct;69(10):2809-18. doi: 10.1093/jac/dku213. Epub 2014 Jun 23. J Antimicrob Chemother. 2014. PMID: 24962031
-
Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.AIDS. 2015 May 15;29(8):911-9. doi: 10.1097/QAD.0000000000000625. AIDS. 2015. PMID: 25730509 Clinical Trial.
-
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.Retrovirology. 2018 Jan 30;15(1):15. doi: 10.1186/s12977-018-0398-1. Retrovirology. 2018. PMID: 29378611 Free PMC article. Review.
-
Raltegravir: the first HIV integrase inhibitor.Clin Ther. 2008 Oct;30(10):1747-65. doi: 10.1016/j.clinthera.2008.10.012. Clin Ther. 2008. PMID: 19014832 Review.
Cited by
-
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells.Clin Microbiol Rev. 2022 Dec 21;35(4):e0005222. doi: 10.1128/cmr.00052-22. Epub 2022 Sep 14. Clin Microbiol Rev. 2022. PMID: 36102816 Free PMC article. Review.
-
Towards an HIV-1 cure: measuring the latent reservoir.Trends Microbiol. 2015 Apr;23(4):192-203. doi: 10.1016/j.tim.2015.01.013. Epub 2015 Mar 5. Trends Microbiol. 2015. PMID: 25747663 Free PMC article. Review.
-
Extremely High Mutation Rate of HIV-1 In Vivo.PLoS Biol. 2015 Sep 16;13(9):e1002251. doi: 10.1371/journal.pbio.1002251. eCollection 2015. PLoS Biol. 2015. PMID: 26375597 Free PMC article.
-
Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection.EBioMedicine. 2019 Mar;41:455-464. doi: 10.1016/j.ebiom.2019.02.016. Epub 2019 Feb 23. EBioMedicine. 2019. PMID: 30803934 Free PMC article.
-
Modeling the timing of antilatency drug administration during HIV treatment.J Virol. 2014 Dec;88(24):14050-6. doi: 10.1128/JVI.01701-14. Epub 2014 Sep 24. J Virol. 2014. PMID: 25253352 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials